비알콜성 지방간병과 대사증후군

키워드

참고문헌 (56)

1. Kleiner DE, "Design and validation of a histological scoring system for nonalcoholic fatty liver disease", Hepatology, 41, pp.1313~1321 (2005)
2. Browning JD, "Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity", Hepatology, 40, pp.1387~1395 (2004)
3. Bedogni G, "Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study", Hepatology, 42, pp.44~52 (2005)
4. Angulo P, "Nonalcoholic fatty liver disease", N Engl J Med, 346, pp.1221~1231 (2002)
5. Moscatiello S, "Diabetes and liver disease: an ominous association", Nutr Metab Cardiovasc Dis, 17, pp.63~70 (2007)
6. Brunt EM, "Nonalcoholic steatohepatitis: definition and pathology", Semin Liver Dis, 21, pp.3~16 (2001)
7. Lavine JE, "Nonalcoholic fatty liver disease in the pediatric population", Clin Liver Dis, 8, pp.549~558 (2004)
8. Romero JR, "Hepatic zonation of the formation and hydrolysis of cholesteryl esters in periportal and perivenous parenchymal cells", Lipids, 34, pp.907~913 (1999)
9. Guzmán M, "Flexibility of zonation of fatty acid oxidation in rat liver", Biochem J, 311(Pt 3), pp.853~860 (1995)
10. Sul HS, "Nutritional and hormonal regulation of enzymes in fat synthesis: studies of fatty acid synthase and mitochondrial glycerol-3-phosphate acyltransferase gene transcription", Annu Rev Nutr, 18, pp.331~351 (1998)
11. Tessari P, "Glycerophosphate acetyltransferase activity in perfused liver of normal and hyperlipemic rats: glucagon effect", Acta Diabetol Lat, 18, pp.357~363 (1981)
12. Julius U, "Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia", Exp Clin Endocrinol Diabetes, 111, pp.246~250 (2003)
13. Browning JD, "Molecular mediators of hepatic steatosis and liver injury", J Clin Invest, 114, pp.147~152 (2004)
14. Foufelle F, "New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c", Biochem J, 366(Pt 2), pp.377~391 (2002)
15. Nosadini R, "Perfused liver carnitine palmitoyl-transferase activity and ketogenesis in streptozotocin treated and genetic hyperinsulinemic rats. Effect of glucagon", Horm Metab Res, 11, pp.661~664 (1979)
16. Shimomura I, "Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus", J Biol Chem, 274, pp.30028~30032 (1999)
17. Yamashita H, "A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver", Proc Natl Acad Sci U S A, 98, pp.9116~9121 (2001)
18. Zhou G, "Role of AMP-activated protein kinase in mechanism of metformin action", J Clin Invest, 108, pp.1167~1174 (2001)
19. Ginsberg HN, "Regulation of plasma triglycerides in insulin resistance and diabetes", Arch Med Res, 36, pp.232~240 (2005)
20. ethanol, "J Lipid Res", 1996, 262~274
21. Day CP, "Steatohepatitis: a tale of two "hits"?", Gastroenterology, 114, pp.842~845 (1998)
22. Feldstein AE, "Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway", Hepatology, 40, pp.185~194 (2004)
23. Yamaguchi K, "Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis", Hepatology, 45, pp.1366~1374 (2007)
24. Roskams T, "Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease", Am J Pathol, 163, pp.1301~1311 (2003)
25. Postic C, "Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice", J Clin Invest, 118, pp.829~838 (2008)
26. Donnelly KL, "Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease", J Clin Invest, 115, pp.1343~1351 (2005)
27. Hudgins LC, "Relationship between carbohydrate-induced hypertriglyceridemia and fatty acid synthesis in lean and obese subjects", J Lipid Res, 41, pp.595~604 (2000)
28. Parks EJ, "Dietary carbohydrate's effects on lipogenesis and the relationship of lipogenesis to blood insulin and glucose concentrations", Br J Nutr, 87(Suppl 2), pp.S247~S253 (2002)
29. Charlton M, "Apolipoprotein synthesis in nonalcoholic steatohepatitis", Hepatology, 35, pp.898~904 (2002)
30. Taniguchi CM, "Critical nodes in signalling pathways: insights into insulin action", Nat Rev Mol Cell Biol, 7, pp.85~96 (2006)
31. McCullough AJ, "Pathophysiology of nonalcoholic steatohepatitis", J Clin Gastroenterol, 40(Suppl 1), pp.S17~29 (2006)
32. Kotronen A, "Liver fat in the metabolic syndrome", J Clin Endocrinol Metab, 92, pp.3490~3497 (2007)
33. Marchesini G, "Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome", Hepatology, 37, pp.917~923 (2003)
34. Marchesini G, "Metabolic syndrome and NASH", Clin Liver Dis, 11, pp.105~117 (2007)
35. Angulo P, "Non-alcoholic fatty liver disease", J Gastroenterol Hepatol, 17(Suppl), pp.S186~190 (2002)
36. Cortez-Pinto H, "Non-alcoholic fatty liver: another feature of the metabolic syndrome?", Clin Nutr, 18, pp.353~358 (1999)
37. Jimba S, "Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults", Diabet Med, 22, pp.1141~1145 (2005)
38. Cai D, "Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB", Nat Med, 11, pp.183~190 (2005)
39. Choi CS, "Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet- induced hepatic steatosis and insulin resistance", J Biol Chem, 282, pp.22678~22688 (2007)
40. Hui JM, "Beyond insulin resistance in NASH: TNF-alpha or adiponectin?", Hepatology, 40, pp.46~54 (2004)
41. Li Z, "Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease", Hepatology, 37, pp.343~350 (2003)
42. Klover PJ, "Interleukin-6 depletion selectively improves hepatic insulin action in obesity", Endocrinology, 146, pp.3417~3427 (2005)
43. van der Poorten D, "Visceral fat: a key mediator of steatohepatitis in metabolic liver disease", Hepatology, 48, pp.449~457 (2008)
44. Lord GM, "Leptin as a proinflammatory cytokine", Contrib Nephrol, 151, pp.151~164 (2006)
45. Berg AH, "ACRP30", adiponectin: an adipokine regulating glucose and lipid metabolism, 2002, pp.13, 84~89
46. Xu A, "The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice", J Clin Invest, 112, pp.91~100 (2003)
47. Sanyal AJ, "Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities", Gastroenterology, 120, pp.1183~1192 (2001)
48. Pérez-Carreras M, "Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis", Hepatology, 38, pp.999~1007 (2003)
49. Kathirvel E, "Overexpression of liver-specific cytochrome P4502E1 impairs hepatic insulin signaling in a transgenic mouse model of nonalcoholic fatty liver disease", Eur J Gastroenterol Hepatol, 21, pp.973~983 (2009)
50. Ron D, "Translational control in the endoplasmic reticulum stress response", J Clin Invest, 110, pp.1383~1388 (2002)
51. Solga SF, "Non-alcoholic fatty liver disease: lumen- liver interactions and possible role for probiotics", J Hepatol, 38, pp.681~687 (2003)
52. Rockall AG, "Hepatic steatosis in Cushing's syndrome: a radiological assessment using computed tomography", Eur J Endocrinol, 149, pp.543~548 (2003)
53. Andrews RC, "Effects of the 11 beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes", J Clin Endocrinol Metab, 88, pp.285~291 (2003)
54. Konopelska S, "Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis", Clin Endocrinol (Oxf), 70, pp.554~560 (2009)
55. Tessari P, "Hepatic lipid metabolism and non-alcoholic fatty liver disease", Nutr Metab Cardiovasc Dis, 19, pp.291~302 (2009)
56. Dowman JK, "Pathogenesis of non-alcoholic fatty liver disease", QJM, 103, pp.71~83 (2010)

관련 논문AI추천